EE20/DRSP(BAY86-5300)

DRUG2 trials

Sponsors

Bayer

Conditions

DysmenorrheaEndometriosis

Phase 3

Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis

CompletedNCT01697111

BayerEndometriosis

Start: 2012-10-31End: 2014-12-31Updated: 2016-02-18

Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea

CompletedNCT01892904

BayerDysmenorrhea

Start: 2013-07-31End: 2015-08-31Updated: 2015-09-09

Related Papers

Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study.

2020-03-104 citations

Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial

Fertility and Sterility2017-09-1181 citations